3406 related articles for article (PubMed ID: 6176752)
1. Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.
Springer GF; Murthy SM; Desai PR; Fry WA; Tegtmeyer H; Scanlon EF
Klin Wochenschr; 1982 Feb; 60(3):121-31. PubMed ID: 6176752
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the detection of early lung and breast carcinoma by T antigen.
Springer GF; Fry WA; Desai PR; Semerdjian RA; Tegtmeyer H; Neybert CG; Scanlon EF
Cancer Detect Prev; 1985; 8(1-2):95-100. PubMed ID: 4064056
[TBL] [Abstract][Full Text] [Related]
3. Delayed-type skin hypersensitivity reaction (DTH) to Thomsen-Friedenreich (T) antigen as diagnostic test for human breast adenocarcinoma.
Springer GF; Desai PR; Murthy MS; Scanlon EF
Klin Wochenschr; 1979 Sep; 57(18):961-3. PubMed ID: 228112
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer patient's cell-mediated immune response to Thomsen-Friedenreich (T) antigen.
Springer GF; Murthy MS; Desai PR; Scanlon EF
Cancer; 1980 Jun; 45(12):2949-54. PubMed ID: 6248184
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer patients' autoimmune responses to Thomsen-Friedenreich (T) antigen: diagnostic utility.
Fry WA; Springer GF; Desai PR
Klin Wochenschr; 1983 Aug; 61(16):817-8. PubMed ID: 6632723
[TBL] [Abstract][Full Text] [Related]
6. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
Hollinshead AC; Stewart TH; Herberman RB
J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
[No Abstract] [Full Text] [Related]
7. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
8. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
9. Human carcinoma-associated precursor antigens of the NM blood group system.
Springer GF; Desai PR; Murthy MS; Scanlon EF
J Surg Oncol; 1979; 11(2):95-106. PubMed ID: 220469
[TBL] [Abstract][Full Text] [Related]
10. Delayed-type cutaneous hypersensitivity to Thomsen-Friedenreich (T) antigen in patients with pancreatic cancer.
Goodale RL; Springer GF; Shearen JG; Desai PR; Tegtmeyer H
J Surg Res; 1983 Oct; 35(4):293-7. PubMed ID: 6621025
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes in patients with lung neoplasms.
Tincani A; Balestrieri G; Moraschini AT; Fadini A; Tassi G; Rugarli C
Ric Clin Lab; 1980; 10(2):397-403. PubMed ID: 6256844
[TBL] [Abstract][Full Text] [Related]
13. Blood group MN precursors as human breast carcinoma-associated antigens and "naturally" occurring human cytotoxins against them.
Springer GF; Desai PR; Scanlon EF
Cancer; 1976 Jan; 37(1):169-76. PubMed ID: 55297
[TBL] [Abstract][Full Text] [Related]
14. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
[No Abstract] [Full Text] [Related]
15. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
Stein R; Chen S; Grossman W; Goldenberg DM
Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
[TBL] [Abstract][Full Text] [Related]
16. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
Paluch E; Ioachim HL
J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
[TBL] [Abstract][Full Text] [Related]
17. Blood group MN antigens and precursors in normal and malignant human breast glandular tissue.
Springer GF; Desai PR; Banatwala I
J Natl Cancer Inst; 1975 Feb; 54(2):335-9. PubMed ID: 163330
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of monoclonal antibodies directed against lung cancer antigens with human lung, breast and colon cancer cell lines.
Schumacher U; Mukthar D; Schenker T
Dis Markers; 1993 Dec; 11(5-6):225-37. PubMed ID: 8082312
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies that demonstrate specificity for several types of human lung cancer.
Cuttitta F; Rosen S; Gazdar AF; Minna JD
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4591-5. PubMed ID: 6270685
[TBL] [Abstract][Full Text] [Related]
20. Immunological monitoring and immunotherapy in carcinoma of the lung.
Weese JL; Herberman RB; Perlin E; Mills M; Heims W; Blom J; Green D; Reid J; Bellinger S; Law I; McCoy JL; Dean JH; Cannon GB; Djeu J
Int J Cancer; 1976 Dec; 18(6):739-49. PubMed ID: 186417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
